Kiora Pharmaceuticals, Inc. Common Stock
Symbol: KPRX (NASDAQ)
Company Description:
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
- Today's Open: $2.49
- Today's High: $2.54
- Today's Low: $2.22
- Today's Volume: 93.02K
- Yesterday Close: $2.47
- Yesterday High: $2.62
- Yesterday Low: $2.44
- Yesterday Volume: 124.63K
- Last Min Volume: 0
- Last Min High: $2.54
- Last Min Low: $2.493
- Last Min VWAP: $0
- Name: Kiora Pharmaceuticals, Inc. Common Stock
- Website: https://www.kiorapharma.com
- Listed Date: 2015-02-13
- Location: ENCINITAS, CA
- Market Status: Active
- CIK Number: 0001372514
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $8.48M
- Round Lot: 100
- Outstanding Shares: 3.43M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-19 | EFFECT | View |
2025-09-15 | S-3 | View |
2025-08-14 | SCHEDULE 13G/A | View |
2025-08-14 | SCHEDULE 13G | View |
2025-08-13 | SCHEDULE 13G/A | View |
2025-08-13 | 8-K | View |
2025-08-08 | 8-K | View |
2025-08-08 | 10-Q | View |
2025-07-01 | UPLOAD | View |
2025-06-20 | CORRESP | View |
2025-06-10 | UPLOAD | View |
2025-06-04 | 8-K | View |
2025-06-03 | 8-K | View |
2025-05-09 | 8-K | View |
2025-05-09 | 10-Q | View |
2025-04-30 | DEF 14A | View |
2025-04-02 | 4 | View |
2025-04-02 | 4 | View |
2025-04-02 | 4 | View |
2025-04-02 | 4 | View |